secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enovix Corp (ENVX)
CIK:        0001828318
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001828318-23-000198
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enovix cuts workforce by 185; shifts Fab1 from manufacturing to R&D; misses Q3 cell production guidance
--------------------------------------------------------------------------------

- Workforce reduction of ~185 personnel (including over 125 contractors) with restructuring charge of ~$2.5M.
- Accelerated depreciation of $36M for Gen1 equipment in Q4 2023–Q1 2024; annualized savings of $22M from restructuring.
- Q3 2023 small cell production cut to 24,000 units vs. guidance of 36,000; expected Q3 revenue only ~$0.2M.
- Fab1 becomes 'Center for Innovation' for R&D; high-volume manufacturing to shift to Asia.
- Strategy pivots from standard cells to custom cells for large customers like smartphone OEMs and U.S. Army.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828318/000182831823000198/0001828318-23-000198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828318/000182831823000198/envx-20231003.htm
  HTML page:      https://secwatch.observer/filing/0001828318-23-000198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer